Richard Federer
Plus aucun poste en cours
Profil
Mr. Richard Federer is Vice President-Global Tax at Horizon Pharma Plc.
Mr. Federer was previously employed as Chief Tax Officer by Fenwal, Inc., Chief Tax Officer by Merisant Co., and Chief Tax Officer by G.D.
Searle & Co., Inc.
He received his undergraduate degree from St. Louis University and a graduate degree from St. Louis University.
Anciens postes connus de Richard Federer
| Sociétés | Poste | Fin |
|---|---|---|
Merisant Co.
 Merisant Co. Food: Major DiversifiedConsumer Non-Durables Merisant Co. is a holding company, which engages in the manufacture and market of tabletop sweeteners. Its flagship brands are Equal, Canderel, and Pure Via. The company was founded on March 20, 2000 and is headquartered in Chicago, IL. | Comptroller/Controller/Auditor | - |
Fenwal, Inc.
 Fenwal, Inc. BiotechnologyHealth Technology Fenwal, Inc. is a global medical technology company focused on improving transfusion medicine through expertise in blood separation, collection, filtration, storage, and transfusion. It offers apheresis collections, manual collections, therapeutics, specialty products, platelet safety, data management, data management, and customer solutions The company was founded in 1949 and is headquartered in Lake Zurich, IL. | Comptroller/Controller/Auditor | - |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Comptroller/Controller/Auditor | - |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Comptroller/Controller/Auditor | - |
Formation de Richard Federer
| St. Louis University | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Fenwal, Inc.
Fenwal, Inc. BiotechnologyHealth Technology Fenwal, Inc. is a global medical technology company focused on improving transfusion medicine through expertise in blood separation, collection, filtration, storage, and transfusion. It offers apheresis collections, manual collections, therapeutics, specialty products, platelet safety, data management, data management, and customer solutions The company was founded in 1949 and is headquartered in Lake Zurich, IL. | Health Technology |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
Merisant Co.
Merisant Co. Food: Major DiversifiedConsumer Non-Durables Merisant Co. is a holding company, which engages in the manufacture and market of tabletop sweeteners. Its flagship brands are Equal, Canderel, and Pure Via. The company was founded on March 20, 2000 and is headquartered in Chicago, IL. | Consumer Non-Durables |
